SUPN logo

Supernus Pharmaceuticals (SUPN)

Profile

Full Name

Supernus Pharmaceuticals, Inc.

Ticker Symbol

SUPN

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

May 1, 2012

Indexes

Not included

Website

http://www.supernus.com

Employees

674

Key Details

Price

$30.76(+0.16%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$661.82M(+8.94% YoY)

Annual EPS

$1.32(+6500.00% YoY)

PE ratio

23.26

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$30.76
SUPN price is $30.76

30-Day Relative Volume

0.72
SUPN 30-day relative volume is 0.72

Price Performance

Price Most recent change

+0.16%
SUPN price was up +0.16% on Apr 17, 2025

Price YTD change

-14.93%
SUPN price is down -14.93% since January 1st

Price 1-year change

+6.07%
SUPN price is up +6.07% year-on-year

Price 3-year change

-1.09%
SUPN price is down -1.09% over the past 3 years

Price Range

Price All-time high

$61.25
SUPN price is currently -49.78% below its historical high of $61.25

Price 3-year low

$21.99
SUPN price is currently +39.88% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.72B
SUPN market capitalization is $1.72 billion

Market cap 3-year change

+3.41%
SUPN market capitalization is up +3.41% over the past 3 years

Market cap All-time high

$3.12B
SUPN market capitalization is currently -45.02% below its historical high of $3.12 billion

Market cap sector rank

81.89%
SUPN market capitalization is higher than 81.89% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.54%
SUPN shares outstanding is up +1.54% year-on-year

Shares Outstanding 3-Year Change

+4.55%
SUPN shares outstanding is up +4.55% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.36
SUPN beta is 0.36

200-day SMA

$33.81
SUPN price is currently -9.02% below its 200-day simple moving average

50-day SMA

$33.19
SUPN price is currently -7.33% below its 50-day simple moving average

RSI

40.39
SUPN 14-day relative strength index is 40.39

Volume

0.72
SUPN 30-day relative volume is 0.72

ATR

$1.29
SUPN average true range is $1.29

10-day Historical Volatility

38.61%
SUPN 10-day historical volatility is 38.61%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$661.82M
SUPN annual revenue is $661.82 million

Revenue Analysts estimate

$623.69M
SUPN annual revenue is currently +6.11% higher than the consensus analysts' forecast

Revenue 1-year change

+8.94%
SUPN annual revenue is up +8.94% year-on-year

Revenue Sector rank

76.57%
SUPN annual revenue is higher than 76.57% of companies in Healthcare sector

EPS

EPS

$1.32
SUPN annual earnings per share is $1.32

EPS Analysts estimate

$1.96
SUPN annual earnings per share is currently -32.77% lower than the consensus analysts' forecast

EPS 1-year change

+6500%
SUPN annual earnings per share is up +6500% year-on-year

EPS Sector rank

90.47%
SUPN annual earnings per share is higher than 90.47% of companies in Healthcare sector

Profit

Gross profit

$583.91M
SUPN annual gross profit is $583.91 million

Gross margin

88.23%
SUPN annual gross profit margin is 88.23%

Operating profit

$75.56M
SUPN annual operating income is $75.56 million

Operating margin

11.42%
SUPN annual operating profit margin is 11.42%

Net income

$73.86M
SUPN annual net profit is $73.86 million

Net margin

11.16%
SUPN annual net profit margin is 11.16%

Expenses

Total expenses

$586.26M
SUPN annual total expenses is $586.26 million

Operating expenses

$508.36M
SUPN annual total operating expenses is $508.36 million

Cost of goods sold

$77.91M
SUPN annual cost of goods sold is $77.91 million

Selling, general & administrative expenses

$321.58M
SUPN annual SGA is $321.58 million

Depreciation and amortization

$80.41M
SUPN annual depreciation & amortization is $80.41 million

Interest expense

$0.00
SUPN annual interest expense is $0.00

Income tax

$24.00M
SUPN annual income tax is $24.00 million

EBIT & EBITDA

EBIT

$97.87M
SUPN annual earnings before interest & taxes is $97.87 million

EBITDA

$178.28M
SUPN annual EBITDA is $178.28 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.37B
SUPN annual total assets is $1.37 billion

Non current assets

$682.00M
SUPN annual long term assets is $682.00 million

Current assets

$686.07M
SUPN annual total current assets is $686.07 million

Cash and cash equivalents

$69.33M
SUPN annual cash & cash equivalents is $69.33 million

Accounts receivable

$142.08M
SUPN annual accounts receivable is $142.08 million

Inventory

$54.29M
SUPN annual inventory is $54.29 million

Liabilities

Total liabilities

$332.34M
SUPN annual total liabilities is $332.34 million

Long term liabilities

$39.94M
SUPN annual total long term liabilities is $39.94 million

Current liabilities

$292.40M
SUPN annual total current liabilities is $292.40 million

Accounts payable

$4.59M
SUPN annual accounts payable is $4.59 million

Debt

Total debt

$34.27M
SUPN annual total debt is $34.27 million

Total debt 1-year change

-17.47%
SUPN annual total debt is down -17.47% year-on-year

Long term debt

$27.38M
SUPN annual long term debt is $27.38 million

Short term debt

$6.89M
SUPN annual short term debt is $6.89 million

Equity & Capital

Shareholders equity

$1.04B
SUPN annual stockholders equity is $1.04 billion

Book value

$1.04B
SUPN annual book value is $1.04 billion

Retained earnings

$556.43M
SUPN annual retained earnings is $556.43 million

Working capital

$393.67M
SUPN annual working capital is $393.67 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$171.95M
SUPN annual cash flow from operations is $171.95 million

Cash from operations 1-year change

+54.79%
SUPN annual cash flow from operations is up +54.79% year-on-year

Cash from investing

-$189.87M
SUPN annual cash flow from investing activities is -$189.87 million

Cash from investing 1-year change

-170.65%
SUPN annual cash flow from investing activities is down -170.65% year-on-year

Cash from financing

$12.19M
SUPN annual cash flow from financing activities is $12.19 million

Cash from financing 1-year change

+103.06%
SUPN annual cash flow from financing activities is up +103.06% year-on-year

CAPEX

CAPEX

$725.00K
SUPN annual capital expenditures is $725.00 thousand

CAPEX 1-year change

+31.58%
SUPN annual capital expenditures is up +31.58% year-on-year

Free Cash Flow

Free cash flow

$171.23M
SUPN annual free cash flow is $171.23 million

Free cash flow 1-year change

+54.91%
SUPN annual free cash flow is up +54.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

88.23%
SUPN annual gross profit margin is 88.23%

Operating margin

11.42%
SUPN annual operating profit margin is 11.42%

Net margin

11.16%
SUPN annual net profit margin is 11.16%

ROA & ROE

ROA

5.58%
SUPN annual return on assets is 5.58%

ROE

7.55%
SUPN annual return on equity is 7.55%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

23.26
SUPN price to earnings ratio is 23.26

PE ratio Sector rank

45.59%
SUPN price to earnings ratio is higher than 45.59% of companies in Healthcare sector

PB Ratio

PB ratio

1.66
SUPN price to book ratio is 1.66

PB ratio Sector rank

57.96%
SUPN price to book ratio is higher than 57.96% of companies in Healthcare sector

PS Ratio

PS ratio

2.59
SUPN price to sales ratio is 2.59

PS ratio Sector rank

48.27%
SUPN price to sales ratio is higher than 48.27% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.68B
SUPN enterprise value is $1.68 billion

Enterprise value Sector rank

80.66%
SUPN enterprise value is higher than 80.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

9.43
SUPN EV/EBITDA is 9.43

EV/EBITDA Sector rank

81.98%
SUPN EV/EBITDA is higher than 81.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.35
SUPN annual current ratio is 2.35

Quick ratio

2.16
SUPN annual quick ratio is 2.16

Leverage

Debt to equity

0.00
SUPN annual debt to equity ratio is 0.00

Interest coverage ratio

-
SUPN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

7
SUPN piotroski f-score is 7

Altman Z-Score

4.73
SUPN altman z-score is 4.73

Analyst ratings

Recent major analysts updates

Feb 26, 25 Cantor Fitzgerald
Neutral
Feb 19, 25 Cantor Fitzgerald
Neutral
Sep 11, 24 Piper Sandler
Neutral
Feb 28, 24 Piper Sandler
Overweight
Nov 9, 23 Piper Sandler
Overweight
Oct 25, 23 Piper Sandler
Overweight
May 10, 23 Piper Sandler
Overweight
Jan 23, 23 Piper Sandler
Overweight
Aug 31, 22 Piper Sandler
Overweight
Apr 13, 21 Jefferies
Buy

Institutional Ownership

Similar stocks

GDRX logo
GoodRx Holdings (GDRX)
NVCR logo
NovoCure Limited (NVCR)
WRBY logo
Warby Parker (WRBY)
QDEL logo
QuidelOrtho (QDEL)
KYMR logo
Kymera Therapeutics (KYMR)
JANX logo
Janux Therapeutics (JANX)
PINC logo
Premier (PINC)
AGL logo
agilon health (AGL)
Ardent Health Partners LLC (ARDT)
  • What is the ticker symbol for Supernus Pharmaceuticals?
  • Does Supernus Pharmaceuticals pay dividends?
  • What sector is Supernus Pharmaceuticals in?
  • What industry is Supernus Pharmaceuticals in?
  • What country is Supernus Pharmaceuticals based in?
  • When did Supernus Pharmaceuticals go public?
  • Is Supernus Pharmaceuticals in the S&P 500?
  • Is Supernus Pharmaceuticals in the NASDAQ 100?
  • Is Supernus Pharmaceuticals in the Dow Jones?
  • When was Supernus Pharmaceuticals's last earnings report?
  • When does Supernus Pharmaceuticals report earnings?
  • Should I buy Supernus Pharmaceuticals stock now?

What is the ticker symbol for Supernus Pharmaceuticals?

The ticker symbol for Supernus Pharmaceuticals is NASDAQ:SUPN

Does Supernus Pharmaceuticals pay dividends?

No, Supernus Pharmaceuticals does not pay dividends

What sector is Supernus Pharmaceuticals in?

Supernus Pharmaceuticals is in the Healthcare sector

What industry is Supernus Pharmaceuticals in?

Supernus Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Supernus Pharmaceuticals based in?

Supernus Pharmaceuticals is headquartered in United States

When did Supernus Pharmaceuticals go public?

Supernus Pharmaceuticals's initial public offering (IPO) was on May 1, 2012

Is Supernus Pharmaceuticals in the S&P 500?

No, Supernus Pharmaceuticals is not included in the S&P 500 index

Is Supernus Pharmaceuticals in the NASDAQ 100?

No, Supernus Pharmaceuticals is not included in the NASDAQ 100 index

Is Supernus Pharmaceuticals in the Dow Jones?

No, Supernus Pharmaceuticals is not included in the Dow Jones index

When was Supernus Pharmaceuticals's last earnings report?

Supernus Pharmaceuticals's most recent earnings report was on Feb 25, 2025

When does Supernus Pharmaceuticals report earnings?

The next expected earnings date for Supernus Pharmaceuticals is May 8, 2025

Should I buy Supernus Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page